Skip to main content
OpenTrials

Clinical trial condition

Liver Diseases

Explore clinical trials studying Liver Diseases. Study availability and eligibility vary by location and protocol.

8,332 public trials 1,293 recruiting studies
Refine in advanced search Browse all conditions

Liver Diseases trial results

Recruiting

A Phase 1 Study of BGB-B2033, Alone or in Combination With Tislelizumab With or Without Bevacizumab, in Participants With Advanced or Metastatic Solid Tumors

NCT06427941

Conditions
Adenocarcinoma, Alpha-fetoprotein (AFP)-Producing Gastric Cancer, Carcinoma, +14 more
Locations
  • City of Hope Phoenix Cancer Center Goodyear, Arizona, United States
  • City of Hope National Medical Center Duarte, California, United States
  • City of Hope Chicago Cancer Center Zion, Illinois, United States
  • Memorial Sloan Kettering Cancer Center Mskcc New York, United States
View all 47 locations
View Trial Details
Recruiting

An Exosome-Based Liquid Biopsy for the Differential Diagnosis of Primary Liver Cancer

NCT06342414

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +15 more
Locations
  • City of Hope Medical Center Duarte, California, United States
  • Graduate School of Medical Sciences, Kyushu University Fukuoka, Japan
  • Graduate School of Medical Sciences, Kumamoto University Kumamoto, Japan
  • Hokkaido University Graduate School of Medicine Sapporo, Japan
View Trial Details
Recruiting

ET140203 T Cells in Pediatric Subjects With Hepatoblastoma, HCN-NOS, or Hepatocellular Carcinoma

NCT04634357

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +14 more
Locations
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • Children's Hospital Orange County Orange, California, United States
  • UCSF Benioff Children's Hospitals San Francisco, California, United States
  • Dana-Farber/Boston Children's Cancer and Blood Disorders Center Boston, Massachusetts, United States
View Trial Details
Recruiting

A Study Observing Everyday Effectiveness and Safety of the Drug Elafibranor in Participants With Primary Biliary Cholangitis Who Are Receiving Ongoing Treatment

NCT06447168

Conditions
Bile Duct Diseases, Biliary Tract Diseases, Cholestasis, +9 more
Locations
  • Southern California Research Center Coronado, California, United States
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • University of California Davis Medical Center Sacramento, California, United States
  • South Denver Gastroenterology,P.C. Englewood, Colorado, United States
View all 68 locations
View Trial Details

Related conditions